Navigation Links
MultiVu Video Feed: SCIELE PHARMA ANNOUNCES AVAILABILITY OF ULESFIA(TM), FIRST AND ONLY FDA-APPROVED NON-NEUROTOXIC HEAD LICE TREATMENT
Date:8/5/2009

Sciele Pharma, Inc., a Shionogi Company, today announced the availability of Ulesfia (Benzyl Alcohol Lotion 5%), the first and only prescription medication that kills head lice by asphyxiation without potential neurotoxic side effects. Approved by the U.S. Food & Drug Administration (FDA), Ulesfia is available now by prescription nationwide in time for peak head lice season as children will shortly be headed back to school.

Each year, approximately 6 to 12 million children between the ages of 3 and 12 years are infested with head lice, parasites that survive by injecting small amounts of saliva and removing small amounts of blood from the scalp every few hours. To survive, lice breathe through sophisticated breathing holes that close upon contact with most liquids, allowing the lice to go into suspended animation and survive for hours without respiration. Ulesfia's unique mechanism of action is facilitated through the use of benzyl alcohol which prevents lice from closing their breathing holes, thereby asphyxiating them and causing death. Ulesfia is an effective head lice treatment that does not contain harsh chemicals and addresses the increasing resistance of lice to therapies that contain neurotoxic chemicals.

Full prescribing information for Ulesfia (Benzyl Alcohol Lotion 5%) is available at www.sciele.com.

    SATELLITE FEEDS:
    Wednesday, August 5th, 2009        Thursday, August 6th, 2009
    1:00 PM - 1:15 PM ET               1:00 PM - 1:15 PM ET
    AMC 3                              AMC 3
    C-Band                             C-Band
    Transponder 3                      Transponder 3
    Downlink Freq. 3760 Horizontal     Downlink Freq. 3760 Horizontal

NEWS: Unique Product Asphyxiates Head Lice, Can Help With Outbreaks as Children Head Back to School

FORMAT: B-roll and Soundbites

ADDITIONAL RESOURCES: Video, contact information and more available at: http://www.prnewswire.com/broadcast/37282/consumer.html


    SOUNDBITES:
    * Ronald Hansen, M.D., Chief of Pediatric Dermatology, Phoenix Children's
      Hospital
    * Judith O'Haver, RN, MS, CPNP, Nurse Practitioner, Phoenix Children's
      Hospital

    B-ROLL INCLUDES:
    * Children at camp and school - Head lice images - Young girl patient
      with doctor -- Nurse combing out girl's hair - Ulesfia product shot

VIDEO PROVIDED BY: Sciele Pharma, Inc., a Shionogi Company

Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations, 1-800-653-5313 EXT. 3


'/>"/>
SOURCE Sciele Pharma, Inc., a Shionogi Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MultiVu Video Feed: PUBLIC HEALTH EXPERTS CONVENE TO DISCUSS THE TREATMENT AND PREVENTION OF RABIES
2. MultiVu Video Feed: FDA Approves DORIBAX(TM) (doripenem for injection) for the Treatment of Complicated Intra-abdominal and Complicated Urinary Tract Infections
3. MultiVu Video Feed: Parents of Kids With Infectious Diseases Sounds Alarm About the Dangers of Pertussis With "Silence the Sounds of Pertussis" Campaign
4. MultiVu Video Feed: STARLIGHT STARBRIGHT UNVEILS GET FIT, GET RIGHT A PROGRAM TO PREVENT TYPE 2 DIABETES AND WEIGHT-RELATED CONDITIONS IN TEENS
5. MultiVu Video Feed: NEW SURVEY FINDS THAT HALF OF CAREGIVERS SPEND 10 PERCENT OF THEIR INCOME CARING FOR AN OLDER LOVED ONE
6. Photo: MultiVu Promotes George DeTorres to Divisional Vice President for the MultiVu Healthcare Team
7. MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS
8. MultiVu Video Feed: LIFE AND STYLE EXPERT SANDRA LEE OFFERS RECIPES AND SHORTCUTS IN THE KITCHEN TO PEOPLE WITH RHEUMATOID ARTHRITIS
9. MultiVu Video Feed: New National Colorectal Cancer Screening Guidelines Issued by the American Cancer Society
10. MultiVu Video Feed: Stinky Sneakers Worth Big Money!
11. MultiVu Video Feed: Podiatrists Keep America Walking
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... Life is known for throwing curves. ... and older, who gather once a year to play softball to raise money through ... game, the more than 50 players who competed in this year’s softball tournament share ...
(Date:2/11/2016)... ... ... Colorado spine surgeon, Donald Corenman, MD, DC has been selected by ... . The list consists of spine surgeons across the country nominated by their peers ... importance of clinical excellence; he has been awarded the Patient’s Choice Award, Compassionate Doctor ...
(Date:2/11/2016)... ... 2016 , ... Talix today announced that Clive Fields, MD, ... at the 2016 HIMSS Annual Conference & Exhibition, taking place February 29 – ... Coding for Care: Using Data Analytics for Risk Adjustment ,” Dr. Fields will ...
(Date:2/11/2016)... AR (PRWEB) , ... February 11, 2016 , ... Dickinson ... their community by announcing a new fundraiser in support of a local boy named ... hopes the campaign will bring awareness to, and rally support for, all local families ...
(Date:2/11/2016)... ... February 11, 2016 , ... Pixel Film Studios brings ... with customizable backdrops in the Christmas edition of the ProDrop series. Pick and choose ... audiences and invoke the spirit of Christmas using ProDrop's wintry generators. ProDrop Christmas is ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... Breast Cancer Therapeutics in Asia-Pacific Markets ... (APAC) breast cancer market will experience considerable expansion ... at a Compound Annual Growth Rate (CAGR) of 8.5%. ... - states that the Asia-Pacific ... billion in 2014 to $3.4 billion by 2021, at a ...
(Date:2/11/2016)... , Feb. 11, 2016 PLAD, Inc. ... out 2016 with sales exceeding company targets, are adding ... received their trademark from the United States Patent and ... Clark , Chief Executive Officer of PLAD, Inc.  In ... Pennsylvania with two new customers, ...
(Date:2/11/2016)... 11, 2016  M3 Biotechnology Inc., spurred by a major "team investment" by Bruce Montgomery ... completed an oversubscribed Series A-Round, according to CEO Leen Kawas , PhD. ... ... ... Kawas said ...
Breaking Medicine Technology: